Focal Interest
Focal Interest
AI Summary of Peer-Reviewed Research

This page presents an AI-generated summary of a published research paper. The original authors did not write or review this article. [See full disclosure ↓]

Publishing process signals: STRONG — reflects the venue and review process. — venue and review process.

D-type mesoporous silica improved celecoxib delivery

A close-up photograph of white granular powder mounded on a dark surface, appearing to be a fine crystalline or particulate material commonly used in materials science research.
Research area:NanotechnologyMaterials ChemistryMesoporous Materials and Catalysis

What the study found

D-type chiral mesoporous silica carriers performed best for delivering celecoxib, a poorly water-soluble anti-inflammatory drug. The study reports that these carriers improved drug dissolution, bioavailability, and anti-inflammatory effect.

Why the authors say this matters

The authors suggest that the D-type carriers may be useful because they achieved both improved drug delivery and a superior anti-inflammatory effect. They describe this as a double synergism in anti-inflammatory drug treatment.

What the researchers tested

The researchers built chiral mesoporous silica xerogels (L-SX and D-SX) using a biomimetic method and chiral mesoporous silica nanoparticles (L-MSNs and D-MSNs) using a chiral grafting method. They loaded celecoxib into these carriers and compared them with a control carrier, then evaluated carrier characteristics, in vivo pharmacokinetics, and pharmacodynamics.

What worked and what didn't

All of the chiral carriers formed hydrogen bonds with the drug and converted celecoxib from a crystalline phase to an amorphous state, which improved dissolution compared with the raw drug. D-SX and D-MSNs were reported as the best carriers, possibly because of their chiral grafted groups, while the abstract does not report comparable superiority for the L-type carriers.

What to keep in mind

The abstract does not provide detailed numerical results, study size, or statistical values. It also does not describe limitations, so scope constraints are not stated in the available summary.

Key points

  • The study focused on celecoxib, a poorly water-soluble anti-inflammatory drug.
  • Both chiral silica xerogels and chiral silica nanoparticles were tested as drug carriers.
  • All chiral carriers formed hydrogen bonds with celecoxib and helped change it from crystalline to amorphous form.
  • D-SX and D-MSNs were reported as the best carriers.
  • The abstract says these D-type carriers improved dissolution, bioavailability, and anti-inflammatory effect.

Disclosure

Research title:
D-type mesoporous silica improved celecoxib delivery
Authors:
Xue Yan, Lu Wang, Zheng Zhang, Xianbao Shi, Guowei Li
Institutions:
Jinzhou Medical University
Publication date:
2026-04-06
DOI:
10.1016/j.mtadv.2026.100767
OpenAlex record:
View
AI provenance: This post was generated by OpenAI. The original authors did not write or review this post.

More posts